(Q45237090)

11 December 2017

In vivo overexpression of CTLA-4 suppresses lymphoproliferative diseases and thymic negative selection (English)

1 reference

11 December 2017

1 reference

Takashi Saito

9

0 references

author name string

Shigekazu Takahashi

1

1 reference

11 December 2017

Hiroshi Kataoka

2

1 reference

11 December 2017

Satoru Hara

3

1 reference

11 December 2017

Tadashi Yokosuka

4

1 reference

11 December 2017

Kan Takase

5

1 reference

11 December 2017

Sho Yamasaki

6

1 reference

11 December 2017

Wakana Kobayashi

7

1 reference

11 December 2017

Yasushi Saito

8

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

European Journal of Immunology

11 December 2017

1 reference

11 December 2017

35

1 reference

11 December 2017

399-407

1 reference

11 December 2017

2

1 reference

The quantity of TCR signal determines positive selection and lineage commitment of T cells.

11 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

Structural analysis of CTLA-4 function in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

A role for the B7-1/B7-2:CD28/CTLA-4 pathway during negative selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

Negative regulation of T cell activation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

T-cell regulation by CD28 and CTLA-4.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

CTLA-4: new insights into its biological function and use in tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

Normal thymic selection, normal viability and decreased lymphoproliferation in T cell receptor-transgenic CTLA-4-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

Thymocyte development is normal in CTLA-4-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

T-cell development and the CD4-CD8 lineage decision

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

Positive and negative selection of T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

Cytotoxic T lymphocyte antigen 4 is induced in the thymus upon in vivo activation and its blockade prevents anti-CD3-mediated depletion of thymocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

Molecular basis of T cell inactivation by CTLA-4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

Cytotoxic T lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tail

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

Cutting edge: tyrosine-independent transmission of inhibitory signals by CTLA-4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

The inhibitory function of CTLA-4 does not require its tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

Without peripheral interference, thymic deletion is mediated in a cohort of double-positive cells without classical activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200324746

7 January 2021

Identifiers

DOI

10.1002/EJI.200324746

1 reference

11 December 2017

1 reference